Video: Superheroes, Secret Identities & You| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Psychosocial Factors & Pain in Hand Osteoarthritis

Ruth Jessen Hickman, MD  |  Issue: June 2025  |  June 7, 2025

Comorbidities

The group also used the Hospital Anxiety and Depression Scale (HADS) to measure signs of anxiety and depression.12 Participants with fewer signs of depression and anxiety at initial assessment were more likely to have pain improvement four years later, reinforcing previous findings of the effects of mental health on pain perception.1,3

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Depression is a common comorbidity in osteoarthritis, and patients with major depressive disorder are more likely to experience chronic pain than those in the general population. It’s possible that underlying features, such as increased chronic inflammation, may be partly driving the association of osteoarthritis pain with depression and anxiety.13

Higher initial body mass index (BMI) was also associated with pain deterioration longitudinally. This is consistent with previous crosssectional reports, and some have speculated the association stems from the increased inflammation triggered by adipokines from excess adipose tissue.14

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Future Directions

Dr. van der Meulen

Given the limits of observational studies, Dr. van der Meulen emphasizes the need for replication in other longitudinal hand OA cohorts, such as the Nor-Hand cohort or DIGICOD cohort.6,15 Theoretically, further studies may help identify specific targets for interventions in certain populations of patients with hand OA. For example, teaching specific coping styles or targeting mental health issues may prove useful for some patients.

“For everyone dealing with patients who are experiencing chronic pain, such as from some kind of rheumatic disease, we may need to start looking more at the biopsychosocial model in its entirety,” says Dr. van der Meulen. “That would mean the paradigm has to shift.”

Dr. van der Meulen acknowledges that it is hard to know how to apply these results and the overall biopsychosocial pain model to patients at present. Current ACR guidelines acknowledge that interventions to improve mood, reduce stress and manage weight may improve patients’ overall well-being. Cognitive behavioral therapy, one mode of working with patient beliefs and perceptions, is already conditionally recommended as a potential component of hand OA treatment for some patients.16

“The main thing right now is to have an open mind and see where rheumatology connects to this larger model of pain,” adds Dr. van der Meulen. “And make sure patients know that increasing pain in hand OA is not a given, that it’s often stable or might even improve.”


Ruth Jessen Hickman, MD, photoRuth Jessen Hickman, MD, a graduate of the Indiana University School of Medicine, is a medical and science writer in Bloomington, Ind.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:AnalgesicsConditionsOsteoarthritis and Bone Disorders Tagged with:biopsychosocialChronic paincoping styleshand osteoarthritishand painNonsteroidal anti-inflammatory drugs (NSAIDs)NSAIDsPain Managementpain perceptionpatient education

Related Articles

    7 Tools to Identify Depression

    August 1, 2014

    Why screening for depressive symptoms in patients with arthritis is needed

    Depression in Rheumatoid Arthritis

    November 1, 2012

    Examining the psychological and health-related comorbidities of rheumatoid arthritis patients with depression

    Désirée Van Der Heijde, MD, PhD, a Key Driver of Treatment Advances

    May 8, 2012

    Dr. van der Heijde learned early in her career that serendipity often plays a role in clinical research and treatment advances.

    Glucocorticoids May Decrease White Matter Integrity & Change Gray Matter Volume

    February 27, 2023

    Van der Meulen et al. found the use of both systemic and inhaled glucocorticoids is associated with changes in several brain imaging parameters, including decreased white matter integrity and gray matter volume. Study patients also reported more depressive symptoms and tiredness than controls.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences